Cargando…
Current therapeutics against HCV
Hepatitis C is a positive stranded enveloped RNA virus belonging to the Flaviviridae family. HCV infection leads to severe liver diseases, cirrhosis and hepatocellular carcinoma worldwide. Although treatments have been available for a while, due to its complexity and genetic diversity, only few are...
Autores principales: | Bhattacharjee, Chayan, Singh, Maitri, Das, Debisukti, Chaudhuri, Sujit, Mukhopadhyay, Aparna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279913/ https://www.ncbi.nlm.nih.gov/pubmed/34307769 http://dx.doi.org/10.1007/s13337-021-00697-0 |
Ejemplares similares
-
Generation of fluorescent HCV pseudoparticles to study early viral entry events- involvement of Rab1a in HCV entry
por: Bhattacharjee, Chayan, et al.
Publicado: (2022) -
HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection
por: Wang, Yuhan, et al.
Publicado: (2021) -
Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010) -
Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
por: Major, Marian E.
Publicado: (2009) -
The Role of RASs /RVs in the Current Management of HCV
por: Malandris, Konstantinos, et al.
Publicado: (2021)